Literature DB >> 14654062

Mitochondrial ATP-sensitive potassium channels in surgical cardioprotection.

James D McCully1, Sidney Levitsky.   

Abstract

ATP-sensitive potassium channels allow for the coupling of membrane potential to cellular metabolic status. Two K(ATP) channel subtypes coexist in the myocardium with one subtype located in the sarcolemma membrane and the other in the inner membrane of the mitochondria. The ATP-sensitive potassium channels can be pharmacologically modulated by a family of structurally diverse agents of varied potency and selectivity, collectively known as potassium channel openers and blockers. Sufficient evidence exists to indicate that the ATP-sensitive potassium channels and in particular the mitochondrial ATP-sensitive potassium channels play an important role both as a trigger and an effector in surgical cardioprotection. In this review, the biochemistry and specificity of the ATP-sensitive potassium channels is examined in relation to surgical cardioprotection.

Mesh:

Substances:

Year:  2003        PMID: 14654062     DOI: 10.1016/j.abb.2003.06.003

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

Review 1.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

2.  Age- and gender-related differences in ischemia/reperfusion injury and cardioprotection: effects of diazoxide.

Authors:  James D McCully; Yoshiya Toyoda; Hidetaka Wakiyama; Anthony J Rousou; Robert A Parker; Sidney Levitsky
Journal:  Ann Thorac Surg       Date:  2006-07       Impact factor: 4.330

3.  BKCa channel activation increases cardiac contractile recovery following hypothermic ischemia/reperfusion.

Authors:  Brenda Cordeiro; Dmitry Terentyev; Richard T Clements
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-12       Impact factor: 4.733

Review 4.  Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?

Authors:  Geoffrey P Dobson; Giuseppe Faggian; Francesco Onorati; Jakob Vinten-Johansen
Journal:  Front Physiol       Date:  2013-08-28       Impact factor: 4.566

5.  Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase.

Authors:  José Luis Guerrero-Orriach; Daniel Ariza-Villanueva; Ana Florez-Vela; Lourdes Garrido-Sánchez; María Isabel Moreno-Cortés; Manuel Galán-Ortega; Alicia Ramírez-Fernández; Juan Alcaide Torres; Concepción Santiago Fernandez; Isabel Navarro Arce; José María Melero-Tejedor; Manuel Rubio-Navarro; José Cruz-Mañas
Journal:  Ther Clin Risk Manag       Date:  2016-04-21       Impact factor: 2.423

6.  A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy.

Authors:  Borami Shin; Mossab Y Saeed; Jesse J Esch; Alvise Guariento; David Blitzer; Kamila Moskowitzova; Giovanna Ramirez-Barbieri; Arzoo Orfany; Jerusha K Thedsanamoorthy; Douglas B Cowan; James A Inkster; Erin R Snay; Steven J Staffa; Alan B Packard; David Zurakowski; Pedro J Del Nido; James D McCully
Journal:  JACC Basic Transl Sci       Date:  2019-12-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.